Abstract:Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80-85% of all patients with lung cancer and 5-year relative overall survival (OS) rate is less than 20%, so that identifying novel diagnostic and prognostic biomarkers is urgently demanded. The present study attempted to identify potential key genes associated with the pathogenesis and prognosis of NSCLC. Methods: Four GEO datasets (GSE18842, GSE19804, GSE43458, and GSE62113) were obtained from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) between NSCLC samples and normal ones were analyzed using limma package, and RobustRankAggreg (RRA) package was used to conduct gene integration. Moreover, Search Tool for the Retrieval of Interacting Genes database (STRING), Cytoscape, and Molecular Complex Detection (MCODE) were utilized to establish protein-protein interaction (PPI) network of these DEGs. Furthermore, functional enrichment and pathway enrichment analyses for DEGs were performed by Funrich and OmicShare. While the expressions and prognostic values of top genes were carried out through Gene Expression Profiling Interactive Analysis (GEPIA) and Kaplan Meier-plotter (KM) online dataset. Results: A total of 249 DEGs (113 upregulated and 136 downregulated) were identified after gene integration. Moreover, the PPI network was established with 166 nodes and 1784 protein pairs. Topoisomerase II alpha (TOP2A), a top gene and hub node with higher node degrees in module 1, was significantly enriched in mitotic cell cycle pathway. In addition, Interleukin-6 (IL-6) was enriched in amb2 integrin signaling pathway. The mitotic cell cycle was the most significant pathway in module 1 with the highest P-value. Besides, five hub genes with high degree of connectivity were selected, including TOP2A, CCNB1, CCNA2, UBE2C, and KIF20A, and they were all correlated with worse OS in NSCLC. Conclusion: The results showed that TOP2A, CCNB1, CCNA2, UBE2C, KIF20A, and IL-6 may be potential key genes, while the mitotic cell cycle pathway may be a potential pathway contribute to progression in NSCLC. Further, it could be used as a new biomarker for diagnosis and to direct the synthesis medicine of NSCLC.

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma.

Prognostic Significance of TOP2A in Non-Small Cell Lung Cancer Revealed by Bioinformatic Analysis

Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics

Elucidating the prognostic and therapeutic significance of TOP2A in various malignancies

Prognostic Value of TOP2A in Bladder Urothelial Carcinoma and Potential Molecular Mechanisms

Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis

Expression and potential molecular mechanism of TOP2A in metastasis of non-small cell lung cancer

Oncogenic role and potential regulatory mechanism of topoisomerase II in a pan-cancer analysis

Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma

Topoisomerase II Alpha Promotes Gallbladder Cancer Proliferation and Metastasis Through Activating Phosphatidylinositol 3-Kinase/protein Kinase B/mammalian Target of Rapamycin Signaling Pathway.

The Prognostic Significance of Topoisomerase II Alpha Protein in Early Stage Luminal Breast Cancer

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Bioinformatics Analysis and Screening of Potential Target Genes Related to the Lung Cancer Prognosis

Identification of Topoisomerase 2A As a Novel Bone Metastasis-Related Gene in Liver Hepatocellular Carcinoma.

Mining Expression and Prognosis of Topoisomerase Isoforms in Non-Small-cell Lung Cancer by Using Oncomine and Kaplan–Meier Plotter

Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis

Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma

GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma

TOP 2 Ahigh is the phenotype of recurrence and metastasis whereas TOP 2

Bioinformatics Analysis Shows That TOP2A Functions As a Key Candidate Gene in the Progression of Cervical Cancer

TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation